Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Report

China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Market Research Report 2023-2029

  • POSTDATE：Aug 29, 2023
  • PAGES：229
  • REPORT CODE：GMM1765188
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pharmaceutical Product Development

    • Lonza AG

    • Almac Group

    • AbbVie Inc

    • Patheon Inc

    • Vetter

    • WuXi AppTec

    • CMIC Group

    • Catalant

    • Nectar Lifesciences

    • Grifols International, SA

    By Type:

    • Peptide Hormone

    • Other Drug Classes

    • Insulin

    • Immunoglobulin

    • Cytokines

    • Blood Factors

    • Monoclonal Antibodies (mAbs)

    By Application:

    • Biotech Company

    • Pharma Company

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Overview 2018-2029

    • 1.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Development Overview

    • 1.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Development History

    • 1.3 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Market Size (2018-2029)

    • 1.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis by Type from Production Side

      • 1.4.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Peptide Hormone (2018-2029)

      • 1.4.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Other Drug Classes (2018-2029)

      • 1.4.3 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Insulin (2018-2029)

      • 1.4.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Immunoglobulin (2018-2029)

      • 1.4.5 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Cytokines (2018-2029)

      • 1.4.6 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Blood Factors (2018-2029)

      • 1.4.7 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (mAbs) (2018-2029)

    • 1.5 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume, Sales Value and Growth Rate of Biotech Company (2018-2029)

      • 1.5.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume, Sales Value and Growth Rate of Pharma Company (2018-2029)

    • 1.6 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis by Region

      • 1.6.1 North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Development

    Chapter 3 Pharma Contract Manufacturing Organisations (Cmos) for Injectable DrugIndustry Chain Analysis

    • 3.1 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Chain

    • 3.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market

    • 3.3 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market

    Chapter 4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 4.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Peptide Hormone

      • 4.5.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Other Drug Classes

      • 4.5.3 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Insulin

      • 4.5.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Immunoglobulin

      • 4.5.5 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Cytokines

      • 4.5.6 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Blood Factors

      • 4.5.7 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Monoclonal Antibodies (mAbs)

    Chapter 5 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate of Biotech Company

      • 5.5.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate of Pharma Company

    Chapter 6 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Region

    • 6.1 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Production Value, by Region

    • 6.2 China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 7.1 North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 7.2 North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 8 Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 8.1 Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 8.2 Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 9 South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 9.1 South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 9.2 South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 10 East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 10.1 East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 10.2 East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 11 Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 11.1 Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 11.2 Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 12 Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 12.1 Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 12.2 Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 13 Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Analysis

    • 13.1 Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Type

    • 13.2 Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pharmaceutical Product Development

        • 14.1.1 Pharmaceutical Product Development Company Profile

        • 14.1.2 Pharmaceutical Product Development Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Lonza AG

        • 14.2.1 Lonza AG Company Profile

        • 14.2.2 Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Almac Group

        • 14.3.1 Almac Group Company Profile

        • 14.3.2 Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 AbbVie Inc

        • 14.4.1 AbbVie Inc Company Profile

        • 14.4.2 AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Patheon Inc

        • 14.5.1 Patheon Inc Company Profile

        • 14.5.2 Patheon Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Vetter

        • 14.6.1 Vetter Company Profile

        • 14.6.2 Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 WuXi AppTec

        • 14.7.1 WuXi AppTec Company Profile

        • 14.7.2 WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 CMIC Group

        • 14.8.1 CMIC Group Company Profile

        • 14.8.2 CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Catalant

        • 14.9.1 Catalant Company Profile

        • 14.9.2 Catalant Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Nectar Lifesciences

        • 14.10.1 Nectar Lifesciences Company Profile

        • 14.10.2 Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Grifols International, SA

        • 14.11.1 Grifols International, SA Company Profile

        • 14.11.2 Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Performance

        • 14.11.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Research Conclusions

    • 15.2 Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Market Size (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Peptide Hormone (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Other Drug Classes (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Insulin (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Immunoglobulin (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Cytokines (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Blood Factors (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (mAbs) (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume, Sales Value and Growth Rate of Biotech Company (2018-2029)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume, Sales Value and Growth Rate of Pharma Company (2018-2029)

    • Figure North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate from 2018-2029

    • Figure Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Share by Type in 2018

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Share by Type in 2023

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Peptide Hormone (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Other Drug Classes (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Insulin (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Immunoglobulin (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Cytokines (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Blood Factors (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume and Growth Rate of Monoclonal Antibodies (mAbs) (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Share by Application in 2018

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Share by Application in 2023

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate of Biotech Company (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Market Size and Growth Rate of Pharma Company (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Region (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Value by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Value Share by Region (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Value Share by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Region (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Value by Region (2018-2023)

    • Table China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Value Share by Region (2018-2023)

    • Figure China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Value Share by Region (2018-2023)

    • Table North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume by Type (2018-2023)

    • Table Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Sales Volume Share by Application (2018-2023)

    • Table Pharmaceutical Product Development Company Profile

    • Table Pharmaceutical Product Development Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Lonza AG Company Profile

    • Table Lonza AG Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Almac Group Company Profile

    • Table Almac Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Patheon Inc Company Profile

    • Table Patheon Inc Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Vetter Company Profile

    • Table Vetter Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table WuXi AppTec Company Profile

    • Table WuXi AppTec Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table CMIC Group Company Profile

    • Table CMIC Group Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Catalant Company Profile

    • Table Catalant Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Nectar Lifesciences Company Profile

    • Table Nectar Lifesciences Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)

    • Table Grifols International, SA Company Profile

    • Table Grifols International, SA Pharma Contract Manufacturing Organisations (Cmos) for Injectable Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US